Takara Bio Inc
TSE:4974
Intrinsic Value
Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. [ Read More ]
The intrinsic value of one Takara Bio Inc stock under the Base Case scenario is 902.83 JPY. Compared to the current market price of 1 008 JPY, Takara Bio Inc is Overvalued by 10%.
Valuation Backtest
Takara Bio Inc
Run backtest to discover the historical profit from buying and selling Takara Bio Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Takara Bio Inc
Current Assets | 61.9B |
Cash & Short-Term Investments | 35.3B |
Receivables | 8.4B |
Other Current Assets | 18.2B |
Non-Current Assets | 61.1B |
PP&E | 50.5B |
Intangibles | 8.8B |
Other Non-Current Assets | 1.8B |
Current Liabilities | 8.3B |
Accounts Payable | 3.8B |
Accrued Liabilities | 870m |
Other Current Liabilities | 3.7B |
Non-Current Liabilities | 2.5B |
Other Non-Current Liabilities | 2.5B |
Earnings Waterfall
Takara Bio Inc
Revenue
|
47.7B
JPY
|
Cost of Revenue
|
-21.3B
JPY
|
Gross Profit
|
26.4B
JPY
|
Operating Expenses
|
-24.9B
JPY
|
Operating Income
|
1.5B
JPY
|
Other Expenses
|
97m
JPY
|
Net Income
|
1.6B
JPY
|
Free Cash Flow Analysis
Takara Bio Inc
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Takara Bio Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Takara Bio Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Takara Bio Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.
Score
Takara Bio Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Takara Bio Inc
According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 2 040 JPY with a low forecast of 1 313 JPY and a high forecast of 2 835 JPY.
Shareholder Return
Price
Takara Bio Inc
Average Annual Return | -4.11% |
Standard Deviation of Annual Returns | 32.42% |
Max Drawdown | -71% |
Market Capitalization | 121.4B JPY |
Shares Outstanding | 120 415 600 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,539 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Contact
IPO
Employees
Officers
The intrinsic value of one Takara Bio Inc stock under the Base Case scenario is 902.83 JPY.
Compared to the current market price of 1 008 JPY, Takara Bio Inc is Overvalued by 10%.